Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 1, 2014
Boston Scientific will participate in the healthcare conference on May 13, 2014. Learn how to watch the webcast or replay.
-
May 1, 2014
Advanced drug-eluting stent system recently received Japan Ministry of Health, Labor and Welfare approval.
-
Apr 29, 2014
Company exceeds earnings per share guidance on the strength of continued revenue growth.
-
Apr 22, 2014
Clinical trial is designed to establish the safety and effectiveness of both lead families.
-
Apr 17, 2014Event Will Be Held in San Francisco, Site of the Heart Rhythm Society 35th Annual Scientific Sessions
Event will be held in San Francisco, site of the Heart Rhythm Society 35th Annual Scientific Sessions.
-
Apr 15, 2014
Newly approved devices include the DYNAGEN™ MINI and INOGEN™ MINI ICDs, as well as the DYNAGEN™ X4 and INOGEN™ X4 CRT-Ds.
-
Apr 10, 2014
Study to evaluate clinical outcomes and economic value of the Vercise™ Deep Brain Stimulation (DBS) System.
-
Apr 7, 2014
The first implant of the S-ICD System performed in Hong Kong.
-
Apr 7, 2014Innovative handle design enables physician preferences for precision, comfort and control when acquiring tissue samples during diagnostic procedures
Boston Scientific Corporation (NYSE: BSX) has received clearance from the U.S. Food and Drug Administration (FDA) and CE Mark approval in Europe for the Expect™ Slimline (SL) Needle, which is...
-
Apr 1, 2014These and Other Studies Reinforce Global Commitment to the Development of Innovative Therapies to Improve Care for Patients with Cardiovascular Disease
Reinforcing its position as a global leader in bringing new therapies to patients with heart and cardiovascular disease, Boston Scientific Corporation...